Jeil Pharma Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Jeil Pharma Holdings has a total shareholder equity of ₩402.2B and total debt of ₩212.2B, which brings its debt-to-equity ratio to 52.8%. Its total assets and total liabilities are ₩880.0B and ₩477.8B respectively. Jeil Pharma Holdings's EBIT is ₩20.9B making its interest coverage ratio 3.2. It has cash and short-term investments of ₩59.1B.
Key information
52.8%
Debt to equity ratio
₩212.24b
Debt
| Interest coverage ratio | 3.2x |
| Cash | ₩59.13b |
| Equity | ₩402.19b |
| Total liabilities | ₩477.81b |
| Total assets | ₩880.00b |
Recent financial health updates
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively
Feb 27
Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet
Nov 23
Recent updates
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?
Mar 25These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively
Feb 27What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?
Jan 23Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment
Dec 28Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet
Nov 23Financial Position Analysis
Short Term Liabilities: A002620's short term assets (₩384.5B) do not cover its short term liabilities (₩412.6B).
Long Term Liabilities: A002620's short term assets (₩384.5B) exceed its long term liabilities (₩65.2B).
Debt to Equity History and Analysis
Debt Level: A002620's net debt to equity ratio (38.1%) is considered satisfactory.
Reducing Debt: A002620's debt to equity ratio has increased from 19.5% to 52.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A002620 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A002620 has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 4.4% each year.